88 related articles for article (PubMed ID: 21261134)
1. Clinical importance of determination of cytokines in patients with ovary tumours.
Abdullaeva LM
Lik Sprava; 2010; (3-4):56-9. PubMed ID: 21261134
[TBL] [Abstract][Full Text] [Related]
2. Serum and cyst fluid levels of interleukin (IL) -6, IL-8 and tumour necrosis factor-alpha in women with endometriomas and benign and malignant cystic ovarian tumours.
Daraï E; Detchev R; Hugol D; Quang NT
Hum Reprod; 2003 Aug; 18(8):1681-5. PubMed ID: 12871882
[TBL] [Abstract][Full Text] [Related]
3. [Serum cytokines in patients with ovarian cancer and benign ovarian cysts].
Nowak M; Szpakowski M; Malinowski A; Wieczorek A; Maciołek-Blewniewska G; Wilczyński JR; Szpakowski A; Wierzbicka E; Małafiej E; Oszukowski P
Ginekol Pol; 2001 Dec; 72(12A):1444-8. PubMed ID: 11883294
[TBL] [Abstract][Full Text] [Related]
4. Role of Intracystic Cytokines and Nitric Oxide in Ovarian Neoplasms.
Martins-Filho A; Jammal MP; Micheli DC; Tavares-Murta BM; Etchebehere RM; Murta EFC; Nomelini RS
Scand J Immunol; 2017 Dec; 86(6):462-470. PubMed ID: 28960399
[TBL] [Abstract][Full Text] [Related]
5. Serum cytokines and CXCR2: potential tumour markers in ovarian neoplasms.
Micheli DC; Jammal MP; Martins-Filho A; Côrtes JRXM; Souza CN; Nomelini RS; Murta EFC; Tavares-Murta BM
Biomarkers; 2020 Sep; 25(6):474-482. PubMed ID: 32544350
[TBL] [Abstract][Full Text] [Related]
6. Production of interleukin-1 beta and tumour necrosis factor-alpha in patients with benign or malignant ovarian tumours.
Punnonen J; Heinonen PK; Kuoppala T; Jansen CT; Punnonen R
J Cancer Res Clin Oncol; 1991; 117(6):587-92. PubMed ID: 1744165
[TBL] [Abstract][Full Text] [Related]
7. The value of estimating CA 125 in fluids from benign or malignant cysts, in the exudate and blood serum in women with ovarian cancer.
Markowska J; Kopczyński Z; Szewierski Z; Markowski M; Niecewicz R
Eur J Gynaecol Oncol; 1994; 15(1):29-32. PubMed ID: 8206067
[TBL] [Abstract][Full Text] [Related]
8. [Significantly increased interleukin-1A and interleukin-1 soluble type II receptor levels in women with ovarian cancer].
Kondera-Anasz Z; Mielczarek-Palacz A; Switała J
Ginekol Pol; 2003 Sep; 74(9):761-6. PubMed ID: 14674121
[TBL] [Abstract][Full Text] [Related]
9. Different effects of interferons, interleukin-1beta and tumor necrosis factor-alpha in normal (OSE) and malignant human ovarian epithelial cells.
Marth C; Zeimet AG; Herold M; Brumm C; Windbichler G; Müller-Holzner E; Offner F; Feichtinger H; Zwierzina H; Daxenbichler G
Int J Cancer; 1996 Sep; 67(6):826-30. PubMed ID: 8824555
[TBL] [Abstract][Full Text] [Related]
10. [Ceramides and gangliosides in benign and malignant human ovarian tumors].
Andreasian GO; Malykh IaN; Diatlovitskaia EV
Vopr Med Khim; 1996; 42(3):248-53. PubMed ID: 9139460
[TBL] [Abstract][Full Text] [Related]
11. Proinflammatory and immunosuppressive serum, ascites and cyst fluid cytokines in patients with early and advanced ovarian cancer and benign ovarian tumors.
Nowak M; Glowacka E; Szpakowski M; Szyllo K; Malinowski A; Kulig A; Tchorzewski H; Wilczynski J
Neuro Endocrinol Lett; 2010; 31(3):375-83. PubMed ID: 20588232
[TBL] [Abstract][Full Text] [Related]
12. The chemotactic cytokine interleukin-8--a cyst fluid marker for malignant epithelial ovarian cancer?
Ivarsson K; Runesson E; Sundfeldt K; Haeger M; Hedin L; Janson PO; Brännström M
Gynecol Oncol; 1998 Dec; 71(3):420-3. PubMed ID: 9887242
[TBL] [Abstract][Full Text] [Related]
13. [Serum levels of IL-1beta, IL-6 and TNF-alpha in infertile patients with ovarian dysfunction].
Vital Reyes VS; Téllez Velasco S; Hinojosa Cruz JC; Ortiz Romero Mde J; Chavarría Olarte ME; Reyes Fuentes A
Ginecol Obstet Mex; 2005 Nov; 73(11):604-10. PubMed ID: 16579166
[TBL] [Abstract][Full Text] [Related]
14. Tumor necrosis factor alpha as an autocrine and paracrine growth factor for ovarian cancer: monokine induction of tumor cell proliferation and tumor necrosis factor alpha expression.
Wu S; Boyer CM; Whitaker RS; Berchuck A; Wiener JR; Weinberg JB; Bast RC
Cancer Res; 1993 Apr; 53(8):1939-44. PubMed ID: 8385577
[TBL] [Abstract][Full Text] [Related]
15. [The role of tumor necrosis factor and interleukin-6 in polycystic ovary syndrome].
Banaś M; Olszanecka-Glinianowicz M; Zahorska-Markiewicz B
Pol Merkur Lekarski; 2006 Nov; 21(125):489-91. PubMed ID: 17345847
[TBL] [Abstract][Full Text] [Related]
16. Ovarian cancer-induced immunosuppression: relationship to tumor necrosis factor-alpha (TNF-alpha) release from ovarian tissue.
Hassan MI; Kassim SK; Saeda L; Laban M; Khalifa A
Anticancer Res; 1999; 19(6C):5657-62. PubMed ID: 10697636
[TBL] [Abstract][Full Text] [Related]
17. Gonadotropin (LH, FSH) levels in serum and cyst fluid in epithelial tumors of the ovary.
Chudecka-Głaz A; Rzepka-Górska I; Kosmowska B
Arch Gynecol Obstet; 2004 Nov; 270(3):151-6. PubMed ID: 12883823
[TBL] [Abstract][Full Text] [Related]
18. Haptoglobin and proteinase inhibitors in the blood serum of women with inflammatory, benign and neoplastic lesions of the ovary.
Warwas M; Gerber J; Pietkiewicz A
Neoplasma; 1986; 33(1):79-84. PubMed ID: 2421174
[TBL] [Abstract][Full Text] [Related]
19. [Clinicopathologic and prognostic significance of serum levels of cytokines in patients with advanced serous ovarian cancer prior to surgery].
Zhu X; Ying LS; Xu SH; Zhu CH; Xie JB
Zhonghua Bing Li Xue Za Zhi; 2010 Oct; 39(10):666-70. PubMed ID: 21176531
[TBL] [Abstract][Full Text] [Related]
20. [ABO system blood groups and the rhesus factor in tumors and tumorlike processes of the ovaries].
Rybalka AN; Andreeva PV; Tikhonenko LF; Koval'chuk NA
Vopr Onkol; 1979; 25(3):28-30. PubMed ID: 107650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
